ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

Also C-Change new name for National Dialogue on Cancer.

January 16, 2004

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013